1. Catalog
  2. Treatment Options for Platinum Resistant Ovarian C ...
Image For Activity Cover
Treatment Options for Platinum Resistant Ovarian Cancer
Description

This webinar explored a potential new novel therapy treatment for platinum resistant ovarian cancer. The following are the learning objectives:
1. Review novel treatment options for platinum resistant ovarian cancer
2. Identify which patients are candidates for antibody drug conjugate therapy

Recorded live on Monday, November 28
Duration approximately 35 minutes 

Attended previous IGCS webinars? If you have attended IGCS webinars in the past, you may already have an IGCS account and creating a new account is not required. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact education@igcs.org.

If you have questions or need assistance, contact education@igcs.org. 

Faculty Information

Ursula A. Matulonis, MD
Chief of the Division of Gynecologic Oncology at the Dana-Farber Cancer Institute
Professor of Medicine at Harvard Medical School
USA
Kathleen Moore, MD, MS
Director, Oklahoma TSET Phase I Program
Associate Professor, Section of Gynecologic Oncology
USA
Supported in part by
IGCS Membership Information
Not an IGCS member? Join IGCS today and be a part of the leading global society advancing gynecologic cancer care around the world. In addition to complimentary valuable educational resources and training opportunities, you will also be supporting the society’s mission to enhance the care of women with gynecologic cancer worldwide through education and training and public awareness. Click here to learn more about IGCS member benefits.
Summary
Availability: On-Demand
Cost: FREE
Create Account
Recommended
Contact education@igcs.org for assistance.
Powered By